[
    {
        "id": 6649,
        "drug_name": "Cosibelimab (CK-301)",
        "clinical_trial_id": "NCT03212404",
        "has_trial_insight_page": 0,
        "indication": "Cutaneous squamous cell carcinoma (CSCC)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-12-18",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/CKPT\/news\/175788",
        "note": "CRL issued on December 18, 2023.",
        "company_entity_id": 140,
        "company_ticker": "FBIO",
        "company_name": "Fortress Biotech Inc.",
        "company_price": "1.7400",
        "company_change": -0.010000000000000009,
        "company_percent_change": -0.5700000000000001,
        "company_optionable": 1,
        "company_number_of_shares": 8942751,
        "price_change_sparkline": [
            [
                2.69,
                1704171600
            ],
            [
                2.48,
                1704258000
            ],
            [
                2.5,
                1704344400
            ],
            [
                2.42,
                1704430800
            ],
            [
                2.26,
                1704690000
            ],
            [
                2.12,
                1704776400
            ],
            [
                1.94,
                1704862800
            ],
            [
                1.86,
                1704949200
            ],
            [
                1.92,
                1705035600
            ],
            [
                1.81,
                1705381200
            ],
            [
                1.88,
                1705467600
            ],
            [
                1.84,
                1705554000
            ],
            [
                1.9,
                1705640400
            ],
            [
                1.99,
                1705899600
            ],
            [
                2,
                1705986000
            ],
            [
                2.01,
                1706072400
            ],
            [
                2.09,
                1706158800
            ],
            [
                2.06,
                1706245200
            ],
            [
                2.1,
                1706504400
            ],
            [
                2,
                1706590800
            ],
            [
                2.04,
                1706677200
            ],
            [
                1.97,
                1706763600
            ],
            [
                1.85,
                1706850000
            ],
            [
                1.72,
                1707109200
            ],
            [
                1.72,
                1707195600
            ],
            [
                1.75,
                1707282000
            ],
            [
                1.8,
                1707368400
            ],
            [
                1.87,
                1707454800
            ],
            [
                1.92,
                1707714000
            ],
            [
                1.77,
                1707800400
            ],
            [
                1.88,
                1707886800
            ],
            [
                1.88,
                1707973200
            ],
            [
                1.86,
                1708059600
            ],
            [
                1.78,
                1708405200
            ],
            [
                1.73,
                1708491600
            ],
            [
                1.75,
                1708578000
            ],
            [
                1.74,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 6649,
        "drug_name": "Cosibelimab (CK-301)",
        "clinical_trial_id": "NCT03212404",
        "has_trial_insight_page": 0,
        "indication": "Cutaneous squamous cell carcinoma (CSCC)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-12-18",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/CKPT\/news\/175788",
        "note": "CRL issued on December 18, 2023.",
        "company_entity_id": 475,
        "company_ticker": "CKPT",
        "company_name": "Checkpoint Therapeutics Inc.",
        "company_price": "1.9600",
        "company_change": 0.08,
        "company_percent_change": 4.26,
        "company_optionable": 1,
        "company_number_of_shares": 23526035,
        "price_change_sparkline": [
            [
                2.19,
                1704171600
            ],
            [
                2.24,
                1704258000
            ],
            [
                2.44,
                1704344400
            ],
            [
                2.39,
                1704430800
            ],
            [
                2.19,
                1704690000
            ],
            [
                2.1,
                1704776400
            ],
            [
                1.91,
                1704862800
            ],
            [
                1.89,
                1704949200
            ],
            [
                1.94,
                1705035600
            ],
            [
                1.88,
                1705381200
            ],
            [
                1.86,
                1705467600
            ],
            [
                1.82,
                1705554000
            ],
            [
                1.84,
                1705640400
            ],
            [
                1.84,
                1705899600
            ],
            [
                1.75,
                1705986000
            ],
            [
                1.68,
                1706072400
            ],
            [
                1.71,
                1706158800
            ],
            [
                1.68,
                1706245200
            ],
            [
                1.99,
                1706504400
            ],
            [
                1.9,
                1706590800
            ],
            [
                2.04,
                1706677200
            ],
            [
                1.96,
                1706763600
            ],
            [
                1.92,
                1706850000
            ],
            [
                1.85,
                1707109200
            ],
            [
                2,
                1707195600
            ],
            [
                1.93,
                1707282000
            ],
            [
                1.99,
                1707368400
            ],
            [
                2,
                1707454800
            ],
            [
                1.99,
                1707714000
            ],
            [
                1.9,
                1707800400
            ],
            [
                1.99,
                1707886800
            ],
            [
                2.01,
                1707973200
            ],
            [
                2.01,
                1708059600
            ],
            [
                1.98,
                1708405200
            ],
            [
                1.92,
                1708491600
            ],
            [
                1.88,
                1708578000
            ],
            [
                1.96,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 2852,
        "drug_name": "Gefapixant",
        "clinical_trial_id": "NCT03449147",
        "has_trial_insight_page": 0,
        "indication": "Chronic cough",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-12-20",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/MRK\/news\/176508",
        "note": "CRL announced December 20, 2023.",
        "company_entity_id": 383,
        "company_ticker": "MRK",
        "company_name": "Merck & Company Inc.",
        "company_price": "129.4500",
        "company_change": 0.19,
        "company_percent_change": 0.15,
        "company_optionable": 1,
        "company_number_of_shares": 2534023084,
        "price_change_sparkline": [
            [
                113.24,
                1704171600
            ],
            [
                114.77,
                1704258000
            ],
            [
                117.01,
                1704344400
            ],
            [
                117.22,
                1704430800
            ],
            [
                117.38,
                1704690000
            ],
            [
                118.43,
                1704776400
            ],
            [
                118.86,
                1704862800
            ],
            [
                118.43,
                1704949200
            ],
            [
                118.63,
                1705035600
            ],
            [
                118.49,
                1705381200
            ],
            [
                118.13,
                1705467600
            ],
            [
                118.54,
                1705554000
            ],
            [
                118.89,
                1705640400
            ],
            [
                119.43,
                1705899600
            ],
            [
                119.84,
                1705986000
            ],
            [
                118.88,
                1706072400
            ],
            [
                120.13,
                1706158800
            ],
            [
                120.82,
                1706245200
            ],
            [
                121.28,
                1706504400
            ],
            [
                121.66,
                1706590800
            ],
            [
                120.78,
                1706677200
            ],
            [
                126.38,
                1706763600
            ],
            [
                126.41,
                1706850000
            ],
            [
                126.18,
                1707109200
            ],
            [
                126.88,
                1707195600
            ],
            [
                127.47,
                1707282000
            ],
            [
                126.61,
                1707368400
            ],
            [
                125.45,
                1707454800
            ],
            [
                125.34,
                1707714000
            ],
            [
                125.43,
                1707800400
            ],
            [
                125.82,
                1707886800
            ],
            [
                126.54,
                1707973200
            ],
            [
                127.79,
                1708059600
            ],
            [
                127.37,
                1708405200
            ],
            [
                128.12,
                1708491600
            ],
            [
                129.26,
                1708578000
            ],
            [
                129.45,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 6856,
        "drug_name": "LUMAKRAS (Sotorasib) - (CodeBreaK 200)",
        "clinical_trial_id": "NCT04303780",
        "has_trial_insight_page": 1,
        "indication": "Non-small cell lung cancer (NSCLC)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-12-26",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/AMGN\/news\/176987",
        "note": "PDUFA date on December 24, 2023. FDA issued a Complete Response Letter (CRL), noted December 26, 2023. The FDA also issued a new postmarketing requirement (PMR) for an additional confirmatory study to support full approval that will be completed no later than February 2028.",
        "company_entity_id": 372,
        "company_ticker": "AMGN",
        "company_name": "Amgen Inc.",
        "company_price": "289.1800",
        "company_change": 4,
        "company_percent_change": 1.4,
        "company_optionable": 1,
        "company_number_of_shares": 535918901,
        "price_change_sparkline": [
            [
                295.093118563779,
                1704171600
            ],
            [
                298.367631127283,
                1704258000
            ],
            [
                300.828476932583,
                1704344400
            ],
            [
                300.659789921736,
                1704430800
            ],
            [
                308.478929012769,
                1704690000
            ],
            [
                304.886887958259,
                1704776400
            ],
            [
                302.217664080736,
                1704862800
            ],
            [
                300.759017575175,
                1704949200
            ],
            [
                304.142680557463,
                1705035600
            ],
            [
                301.136082658245,
                1705381200
            ],
            [
                301.731448578882,
                1705467600
            ],
            [
                302.138281957984,
                1705554000
            ],
            [
                305.432640052176,
                1705640400
            ],
            [
                307.764489908005,
                1705899600
            ],
            [
                307.516420774406,
                1705986000
            ],
            [
                303.140481257723,
                1706072400
            ],
            [
                307.863717561444,
                1706158800
            ],
            [
                309.362055128381,
                1706245200
            ],
            [
                311.029079706165,
                1706504400
            ],
            [
                312.190043251407,
                1706590800
            ],
            [
                311.832823699025,
                1706677200
            ],
            [
                322.053272003295,
                1706763600
            ],
            [
                320.693853151174,
                1706850000
            ],
            [
                319.483275779212,
                1707109200
            ],
            [
                313.62884422628,
                1707195600
            ],
            [
                293.584858231498,
                1707282000
            ],
            [
                292.572736166415,
                1707368400
            ],
            [
                288.871544693121,
                1707454800
            ],
            [
                292.155980021969,
                1707714000
            ],
            [
                288.236487711108,
                1707800400
            ],
            [
                287.829654332006,
                1707886800
            ],
            [
                289.07,
                1707973200
            ],
            [
                283.7,
                1708059600
            ],
            [
                283.51,
                1708405200
            ],
            [
                283.46,
                1708491600
            ],
            [
                285.18,
                1708578000
            ],
            [
                289.18,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 10481,
        "drug_name": "Zolbetuximab",
        "clinical_trial_id": "NCT03504397",
        "has_trial_insight_page": 0,
        "indication": "HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma whose tumors are CLDN18.2-positive",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2024-01-09",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ALPMY\/news\/179083",
        "note": "CRL issued by the FDA on January 9, 2024.",
        "company_entity_id": 2240,
        "company_ticker": "ALPMY",
        "company_name": "Astellas Pharma Inc. ADR",
        "company_price": "10.9900",
        "company_change": 0.03,
        "company_percent_change": 0.27,
        "company_optionable": 0,
        "company_number_of_shares": 1808873137,
        "price_change_sparkline": [
            [
                11.83,
                1704171600
            ],
            [
                11.76,
                1704258000
            ],
            [
                12.06,
                1704344400
            ],
            [
                12.16,
                1704430800
            ],
            [
                12.28,
                1704690000
            ],
            [
                12.043,
                1704776400
            ],
            [
                12.19,
                1704862800
            ],
            [
                12.104,
                1704949200
            ],
            [
                12.08,
                1705035600
            ],
            [
                12.1,
                1705381200
            ],
            [
                11.73,
                1705467600
            ],
            [
                11.7,
                1705554000
            ],
            [
                11.56,
                1705640400
            ],
            [
                11.57,
                1705899600
            ],
            [
                11.54,
                1705986000
            ],
            [
                11.47,
                1706072400
            ],
            [
                11.44,
                1706158800
            ],
            [
                11.416,
                1706245200
            ],
            [
                11.6,
                1706504400
            ],
            [
                11.57,
                1706590800
            ],
            [
                11.6,
                1706677200
            ],
            [
                11.55,
                1706763600
            ],
            [
                11.35,
                1706850000
            ],
            [
                11,
                1707109200
            ],
            [
                10.89,
                1707195600
            ],
            [
                10.92,
                1707282000
            ],
            [
                10.73,
                1707368400
            ],
            [
                10.79,
                1707454800
            ],
            [
                10.82,
                1707714000
            ],
            [
                10.89,
                1707800400
            ],
            [
                11.075,
                1707886800
            ],
            [
                11.05,
                1707973200
            ],
            [
                11.1,
                1708059600
            ],
            [
                11.14,
                1708405200
            ],
            [
                11.12,
                1708491600
            ],
            [
                10.96,
                1708578000
            ],
            [
                10.99,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 10817,
        "drug_name": "Tesamorelin - (F8 formulation)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Reduction of excess abdominal fat in adults with HIV",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2024-01-24",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/THTX\/news\/181513",
        "note": "CRL issued by FDA on January 24, 2024.",
        "company_entity_id": 2306,
        "company_ticker": "THTX",
        "company_name": "Theratechnologies Inc.",
        "company_price": "1.6350",
        "company_change": 0.03,
        "company_percent_change": 1.55,
        "company_optionable": 1,
        "company_number_of_shares": 45980019,
        "price_change_sparkline": [
            [
                1.69,
                1704171600
            ],
            [
                1.67,
                1704258000
            ],
            [
                1.82,
                1704344400
            ],
            [
                2.25,
                1704430800
            ],
            [
                2.3,
                1704690000
            ],
            [
                2.18,
                1704776400
            ],
            [
                2.09,
                1704862800
            ],
            [
                1.97,
                1704949200
            ],
            [
                1.95,
                1705035600
            ],
            [
                1.955,
                1705381200
            ],
            [
                2.04,
                1705467600
            ],
            [
                2.03,
                1705554000
            ],
            [
                2.01,
                1705640400
            ],
            [
                1.85,
                1705899600
            ],
            [
                1.72,
                1705986000
            ],
            [
                1.48,
                1706072400
            ],
            [
                1.595,
                1706158800
            ],
            [
                1.58,
                1706245200
            ],
            [
                1.71,
                1706504400
            ],
            [
                1.73,
                1706590800
            ],
            [
                1.55,
                1706677200
            ],
            [
                1.66,
                1706763600
            ],
            [
                1.67,
                1706850000
            ],
            [
                1.57,
                1707109200
            ],
            [
                1.65,
                1707195600
            ],
            [
                1.65,
                1707282000
            ],
            [
                1.57,
                1707368400
            ],
            [
                1.6254,
                1707454800
            ],
            [
                1.6773,
                1707714000
            ],
            [
                1.59,
                1707800400
            ],
            [
                1.62,
                1707886800
            ],
            [
                1.63,
                1707973200
            ],
            [
                1.65,
                1708059600
            ],
            [
                1.68,
                1708405200
            ],
            [
                1.7,
                1708491600
            ],
            [
                1.61,
                1708578000
            ],
            [
                1.635,
                1708664400
            ]
        ],
        "statuses": []
    }
]

